Nav: Home

Supramolecular protein fishing with molecular baits

March 01, 2017

Scientists from the Center for Self-assembly and Complexity (CSC) successfully isolated a cancer-prone protein by fishing out the proteins using 'molecular bait'. Cancer, according to the American Cancer Society, affects 1 in 2 men and 1 in 3 women, with prostate and breast cancer the most common types afflicting adults. Histone deacetylases (HDACs) are an important family of proteins that regulate gene expression; an altered expression or mutations of genes that encode HDACs can induce tumors to develop. Therefore HDACs are among the most promising therapeutic targets for cancer treatment and they have inspired researchers to study and develop HDAC inhibitors. Inhibition of proteins involved in disease is an important strategy in the development of a drug. For example, an anti-cancer drug (SAHA) slows down cancer progression by inhibiting HDAC, which causes the cells to stop reproducing.

CSC researchers used SAHA as a molecular bait to capture HDAC and successfully fished out the caught proteins using a bead previously developed at the Center. "In 2011, our research group developed a replacement for the existing streptavidin-biotin binding pair, which was used for the separation and purification of proteins, by taking advantage of a strong artificial host-guest interaction pair based on supramolecular chemistry, which was used to capture cell surface proteins with high purification efficiency. The goal of this study was to purify histone deacetylase, a protein that plays a biologically important role in cells and is closely related to disease mechanisms such as cancer," explains Dr. James Murray, the first author of the paper and a researcher from CSC.

The bead is made from Cucurbit[7]urils [CB[7]], a family of pumpkin-shaped macrocycles. These molecules have received a lot of attention because their high-affinity host-guest chemistry provides a unique opportunity to develop non-covalent materials for a range of applications. According to the team's manuscript, published in the German journal, Angewandte Chemie: "The CB[7]-based enrichment strategy takes advantage of small molecules with exceptionally high binding affinity. In contrast, recombinant methods use larger molecules with lower binding affinity." The IBS team extended this technology to the more complex and function-rich intracellular proteome. Inside the lab researchers labeled a protein of interest with a high-affinity guest for their bead and extracted it from cell lysate using CB[7] beads. The CB[7] beads enriched guest-labeled HDACs from a cell lysate, the team also reported that the method may be useful for enriching proteins labeled from live cells. "We used a drug molecule (SAHA) as the molecular bait that finds HDAC proteins," reveals Dr. Murray. "Our molecule also has a functional group capable of forming a permanent bond with the captured protein when irradiated with ultraviolet light. As a result, it was possible to successfully purify the histone deacetylase from a complex sample."

The team's manuscript went on to clarify, "We demonstrated that affinity-labeled intracellular proteins can be enriched from cell lysates by use of a strong host-guest pair. Notably, this method only uses designed, synthetic molecules to perform the labeling and enrichment, rather than using molecules from nature that have inherent biological background reactivity. The molecular bait strategy is one protein labeling method, we believe that the CB[7] system may be compatible with others too. Furthermore, the CB[7]-system may be used in tandem with conventional Bt-SA enrichments for deep proteome mining. Work along this line is underway in our laboratory."
-end-


Institute for Basic Science

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.